Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern Sweden

OBJECTIVE: Convalescent plasma has been tried as therapy for various viral infections. Early observational studies of convalescent plasma treatment for hospitalized COVID-19 patients were promising, but randomized controlled studies were lacking at the time. The objective of this study was to invest...

Descripción completa

Detalles Bibliográficos
Autores principales: Holm, Karin, Lundgren, Maria N., Kjeldsen-Kragh, Jens, Ljungquist, Oskar, Böttiger, Blenda, Wikén, Christian, Öberg, Jonas, Fernström, Nils, Rosendal, Ebba, Överby, Anna K., Wigren Byström, Julia, Forsell, Mattias, Landin-Olsson, Mona, Rasmussen, Magnus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642769/
https://www.ncbi.nlm.nih.gov/pubmed/34863304
http://dx.doi.org/10.1186/s13104-021-05847-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642769/
https://www.ncbi.nlm.nih.gov/pubmed/34863304
http://dx.doi.org/10.1186/s13104-021-05847-7

Ejemplares similares